Rocksolid Light

News from da outaworlds

mail  files  register  groups  login

Message-ID:  

BOFH excuse #107: The keyboard isn't plugged in


sci / sci.med.pathology / Removal Of Bad Free Iron In Diabetes

SubjectAuthor
o Removal Of Bad Free Iron In Diabetesironjustice

1
Subject: Removal Of Bad Free Iron In Diabetes
From: ironjustice
Newsgroups: sci.med.pathology
Date: Fri, 17 Jan 2020 01:18 UTC
X-Received: by 2002:a05:620a:1265:: with SMTP id b5mr36166788qkl.172.1579223939129;
Thu, 16 Jan 2020 17:18:59 -0800 (PST)
X-Received: by 2002:a25:1f82:: with SMTP id f124mr25217762ybf.471.1579223938845;
Thu, 16 Jan 2020 17:18:58 -0800 (PST)
Path: eternal-september.org!news.eternal-september.org!reader01.eternal-september.org!reader01.eternal-september.org!feeder.eternal-september.org!news.gegeweb.eu!gegeweb.org!usenet-fr.net!proxad.net!feeder1-2.proxad.net!209.85.160.216.MISMATCH!g89no4565592qtd.0!news-out.google.com!w29ni1422qtc.0!nntp.google.com!g89no4565585qtd.0!postnews.google.com!google-groups.googlegroups.com!not-for-mail
Newsgroups: sci.med.pathology
Date: Thu, 16 Jan 2020 17:18:58 -0800 (PST)
Complaints-To: groups-abuse@google.com
Injection-Info: google-groups.googlegroups.com; posting-host=2001:56a:723e:aa00:5d64:b9be:7ce2:46bb;
posting-account=hBAG4AoAAABOaauYJdMbCKnI-qYy_97e
NNTP-Posting-Host: 2001:56a:723e:aa00:5d64:b9be:7ce2:46bb
User-Agent: G2/1.0
MIME-Version: 1.0
Message-ID: <7c0ca81a-f8e0-49cd-ba3c-884dedec24a5@googlegroups.com>
Subject: Removal Of Bad Free Iron In Diabetes
From: teamtanner@hotmail.com (ironjustice)
Injection-Date: Fri, 17 Jan 2020 01:18:59 +0000
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable
View all headers

Finally, a pill that could fix the root cause of diabetes
Concenter Biopharma of Jerusalem is developing a drug to treat and even prevent type 2 diabetes by restoring the body’s insulin sensitivity.

https://www.israel21c.org/finally-a-pill-that-could-fix-the-root-cause-of-diabetes/

--------------------

Developing Novel, First in Class Drug,
Treating and Preventing
Type 2 Diabetes,
Based on a Core-Technology-Platform.

Short summary
Pipeline (IND in process):

Type 2 Diabetes drug

Professor Chevion and co-inventors developed a family of non-steroidal chemical complexes, made of components approved for clinical use.

These New Chemical Entities constitute a protected PLATFORM of DRUGS, with proven efficacy and complete safety, for treatments of multiple indications.. Concenter BioPharma is developing and commercializing the drug which treats and prevents Type 2 Diabetes.

The drug has 3 synergistic Mechanisms of Action, extensively tested in animal models of human diseases (and anecdotal human cases).

Members of our PLATFORM act as:

(i) Potent anti-inflammatory agents,

(ii) Strong iron-chelating agents, and

(iii) Anti-biotic agents.

https://www.concenterbiopharma.com/

Who loves ya.
Tom

Jesus Was A Vegetarian!
http://tinyurl.com/2r2nkh

Man Is A Herbivore!
http://tinyurl.com/4rq595

DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk

1

rocksolid light 0.9.8
clearnet tor